CLINICAL PHARMACOKINETICS IN DRUG SAFETY EVALUATION

被引：0
|
作者：
PARKE, DV
机构：
来源：
ATLA-ALTERNATIVES TO LABORATORY ANIMALS | 1994年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：207 / 209
页数：3
相关论文
共 50 条
  • [21] Clinical Pharmacokinetics and Drug Interactions of Doravirine
    Wilby, Kyle John
    Eissa, Nesma Ahmed
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (06) : 637 - 644
  • [22] Posaconazole: clinical pharmacokinetics and drug interactions
    Lipp, Hans-Peter
    MYCOSES, 2011, 54 : 32 - 38
  • [23] Clinical Pharmacokinetics and Drug Interactions of Doravirine
    Kyle John Wilby
    Nesma Ahmed Eissa
    European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 637 - 644
  • [24] Telaprevir: Clinical Pharmacokinetics, Pharmacodynamics, and Drug–Drug Interactions
    Tony K. L. Kiang
    Kyle J. Wilby
    Mary H. H. Ensom
    Clinical Pharmacokinetics, 2013, 52 : 487 - 510
  • [25] Clinical Pharmacokinetics and Drug–Drug Interactions of Elbasvir/Grazoprevir
    Tony K. L. Kiang
    European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 509 - 531
  • [26] DRUG ASSAYS FOR THE CLINICAL PHARMACOKINETICS LABORATORY
    WILSON, JM
    JOURNAL OF LIQUID CHROMATOGRAPHY, 1987, 10 (2-3): : 277 - 292
  • [27] STEREOSELECTIVITY IN CLINICAL PHARMACOKINETICS AND DRUG DEVELOPMENT
    CAMPBELL, DB
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (02) : 109 - 125
  • [28] Pharmacokinetics, metabolism and drug safety: An industry point of view
    Benichou, C
    THERAPIE, 1996, 51 (05): : 487 - 488
  • [29] Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety
    Dobesh, Paul P.
    Oestreich, Julie H.
    PHARMACOTHERAPY, 2014, 34 (10): : 1077 - 1090
  • [30] Review of the Clinical Pharmacokinetics, Efficacy and Safety of Pembrolizumab
    Homsek, Ana
    Radosavljevic, Davorin
    Miletic, Nebojsa
    Spasic, Jelena
    Jovanovic, Marija
    Miljkovic, Branislava
    Stanojkovic, Tatjana
    Vucicevic, Katarina
    CURRENT DRUG METABOLISM, 2022, 23 (06) : 460 - 472
12345